Next-Generation Targeted Therapies in Non-Small Cell Lung Cancer

preview_player
Показать описание
In this segment, panelists discuss the number of early-phase clinical trials that have demonstrated impressive efficacy for next-generation ALK and EGFR inhibitors for patients with non-small cell lung cancer.

  1. OncLive
  2. cancer
  3. oncology
  4. Epidermal Growth Factor Receptor (Chemical Compound)
  5. Targeted Therapy (Drug)
  6. Non-small Cell Lung Cancer (Disease Or Medical Condition)
Рекомендации по теме
Next-Generation Targeted Therapies 0:07:44

Next-Generation Targeted Therapies in Non-Small Cell Lung Cancer

2023 Best of 0:30:32

2023 Best of Lung: Targeted Therapies in Lung Cancer

Stephen Lyle - 0:46:23

Stephen Lyle - Personalized medicine

Advantages of Next 0:03:20

Advantages of Next Generation Sequencing in NSCLC - 2022 Program: Targeted Therapies Forum - English

Gene Targeted Therapy 0:59:01

Gene Targeted Therapy for Non Small Cell Lung Cancer

Impact of Next-Generation 0:04:00

Impact of Next-Generation Sequencing for Treating mNSCLC

Keynote Lecture: Targeted 0:33:52

Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises

ALK and ROS1 0:40:53

ALK and ROS1 in Lung Cancer Next Generation Targeted Therapies

NGS key for 0:02:57

NGS key for optimal lung cancer treatment

Next-Generation ALK Inhibitors 0:05:53

Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer

Next-Generation Sequencing in 0:15:18

Next-Generation Sequencing in Lung Cancer

The Future of 0:03:02

The Future of RET+ NSCLC Treatment - Targeted Therapies in Lung Cancer 2023

Targeted Therapies 2019 0:31:33

Targeted Therapies 2019 Intro and NGS START

The Unprecedented Data 0:02:31

The Unprecedented Data of Next-Generation Sequencing

Targeted Therapy For 0:02:07

Targeted Therapy For NSCLC | Targeted Therapy For Lung Cancer |

Significance of Next-Generation 0:06:10

Significance of Next-Generation Sequencing in NSCLC

Relevant New Data 1:00:49

Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

Targeted Therapies for 0:02:28

Targeted Therapies for Stage III Non-Small Cell Lung Cancer

Next-Generation ALK-Targeted Agents 0:02:50

Next-Generation ALK-Targeted Agents in NSCLC

Next generation sequencing 0:03:37

Next generation sequencing in lung cancer

Incorporating NGS in 1:03:21

Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population -a cost-effectiveness...

Resistance to Targeted 0:05:22

Resistance to Targeted Therapies and the Importance of Retesting Davies

Next-Generation ALK Inhibitors 0:06:41

Next-Generation ALK Inhibitors for NSCLC

Sequencing Strategies for 0:06:36

Sequencing Strategies for ALK-Targeted Therapy